Cancer Family
Solid Neoplasm
CI-CAN-00000052Explore in graph →
Non-malignant1,823 active trials28 evidence items
- NCIt
- C9292
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000052Explore in graph →
Clinical trials
6,089 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00003768 | Combretastatin A4 Phosphate in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 25 | Case Comprehensive Cancer CenterOTHER | 1 | Jan 7, 2014 | clinicaltrials |
| NCT00769288 | FAU in Treating Patients With Advanced Solid Tumors or Lymphoma | completed | Phase 1 | 12 | National Cancer Institute (NCI)NIH | 1 | Jan 7, 2014 | clinicaltrials |
| NCT00004979 |
| Topotecan and Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Advanced Solid Tumors |
| completed |
| Phase 1 / Phase 2 |
| — |
| Jonsson Comprehensive Cancer CenterOTHER |
| 0 |
| Jan 6, 2014 |
| clinicaltrials |
| NCT00551096 | Gemcitabine/Capecitabine/ZD6474 in Advanced Solid Tumors | completed | Phase 1 | 23 | University of Colorado, DenverOTHER | 1 | Dec 25, 2013 | clinicaltrials |
| NCT00003697 | Dimethylxanthenone Acetic Acid in Treating Patients With Solid Tumors | completed | Phase 1 | 3 | University of GlasgowOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00003698 | Chemotherapy in Treating Patients With Solid Tumors | completed | Phase 1 | 35 | University of GlasgowOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00004036 | Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer | unknown | Phase 1 | 30 | The Cleveland ClinicOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00004051 | Irinotecan in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 40 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00004076 | PNU 166148 in Treating Patients With Metastatic Solid Tumors | unknown | Phase 1 | 30 | University of GlasgowOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00005791 | Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00005996 | SU5416 Combined With Gemcitabine and Cisplatin in Treating Patients With Advanced Solid Tumors | unknown | Phase 1 | — | Jonsson Comprehensive Cancer CenterOTHER | 0 | Dec 19, 2013 | clinicaltrials |
| NCT00006085 | CP-609,754 in Treating Patients With Advanced Solid Tumors | unknown | Phase 1 | — | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00008073 | Octreotide and Doxorubicin in Treating Patients With Advanced Cancer | completed | Phase 1 | — | University of PittsburghOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00008086 | Calcitriol Plus Carboplatin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | University of PittsburghOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00009802 | Calcitriol Plus Paclitaxel in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 45 | University of PittsburghOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00009815 | Combination Chemotherapy in Treating Patients With Advanced Solid Tumors | withdrawn | Phase 1 | 0 | University of PittsburghOTHER | 0 | Dec 19, 2013 | clinicaltrials |
| NCT00009828 | Paclitaxel Combined With Fluorouracil-Uracil and Leucovorin in Treating Patients With Solid Tumors | withdrawn | Phase 1 | 0 | University of PittsburghOTHER | 0 | Dec 19, 2013 | clinicaltrials |
| NCT00072332 | Edotecarin and Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00436761 | Busulfan, Melphalan, and Antithymocyte Globulin Followed By Umbilical Cord Blood Transplant in Treating Young Patients With Refractory or Relapsed Malignant Solid Tumors | unknown | Phase 1 | 20 | Milton S. Hershey Medical CenterOTHER | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00017524 | AG2037 in Treating Patients With Advanced, Metastatic, or Recurrent Solid Tumors | completed | Phase 1 | 22 | University of Alabama at BirminghamOTHER | 1 | Dec 16, 2013 | clinicaltrials |
| NCT00019708 | Geldanamycin Analogue in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma | terminated | Phase 1 | 45 | National Cancer Institute (NCI)NIH | 1 | Dec 16, 2013 | clinicaltrials |
| NCT00070239 | Alvocidib in Treating Patients With Metastatic or Unresectable Refractory Solid Tumors or Hematologic Malignancies | terminated | Phase 1 | 100 | National Cancer Institute (NCI)NIH | 1 | Dec 16, 2013 | clinicaltrials |
| NCT00080990 | Alvocidib, Oxaliplatin, Fluorouracil, and Leucovorin Calcium in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 46 | National Cancer Institute (NCI)NIH | 1 | Dec 16, 2013 | clinicaltrials |
| NCT00243100 | Vorinostat and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 21 | National Cancer Institute (NCI)NIH | 1 | Dec 16, 2013 | clinicaltrials |
| NCT00390052 | 3-AP in Treating Patients With Advanced or Metastatic Solid Tumors | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Dec 16, 2013 | clinicaltrials |
| NCT00007878 | Bortezomib, Fluorouracil, and Leucovorin Calcium in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Dec 11, 2013 | clinicaltrials |
| NCT00021073 | Combination Chemotherapy in Treating Patients With Advanced Cancer | completed | Phase 1 | 90 | National Cancer Institute (NCI)NIH | 1 | Dec 11, 2013 | clinicaltrials |
| NCT00043121 | Combination Chemotherapy in Treating Patients With Advanced Cancer That is Metastatic or Cannot Be Removed By Surgery | completed | Phase 1 | 50 | National Cancer Institute (NCI)NIH | 1 | Dec 11, 2013 | clinicaltrials |
| NCT00103220 | SJG-136 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 36 | National Cancer Institute (NCI)NIH | 1 | Dec 11, 2013 | clinicaltrials |
| NCT00369200 | AFP464 in Treating Patients With Advanced Solid Tumors | terminated | Phase 1 | 60 | National Cancer Institute (NCI)NIH | 1 | Dec 11, 2013 | clinicaltrials |
| NCT01496534 | Phase Ib Study of Gemcitabine Plus Cisplatin or Carboplatin Plus Dovitinib in Patients With Advanced Solid Tumors | terminated | Phase 1 | 14 | Matthew GalskyOTHER | 1 | Nov 27, 2013 | clinicaltrials |
| NCT00927966 | RAD001 in Combination With CP-751,871 in Patients Wtih Advanced Sarcomas and Other Malignant Neoplasms | completed | Phase 1 | 21 | Suzanne George, MDOTHER | 1 | Nov 14, 2013 | clinicaltrials |
| NCT01337544 | Haploidentical Stem Cell Transplantation and IL-15 NK Cell Infusion for Paediatric Refractory Solid Tumours(NK) | terminated | Phase 1 / Phase 2 | 6 | Hospital Infantil Universitario Niño Jesús, Madrid, SpainOTHER | 1 | Nov 11, 2013 | clinicaltrials |
| NCT00708006 | A Study of HGS1029 (AEG40826-2HCl) in Subjects With Advanced Solid Tumors | completed | Phase 1 | 66 | Human Genome Sciences Inc.INDUSTRY | 1 | Nov 7, 2013 | clinicaltrials |
| NCT00002482 | Monoclonal Antibody Plus Cyclophosphamide in Treating Patients With Metastatic Cancer | unknown | Phase 1 / Phase 2 | — | St. Vincent Medical Center - Los AngelesOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT01110486 | ABT-348 as Monotherapy or Combination With Carboplatin or Docetaxel to Treat Advanced Solid Tumors | completed | Phase 1 | 102 | AbbVie (prior sponsor, Abbott)INDUSTRY | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00689065 | Safety Study of CALAA-01 to Treat Solid Tumor Cancers | terminated | Phase 1 | 24 | Calando PharmaceuticalsINDUSTRY | 1 | Nov 1, 2013 | clinicaltrials |
| NCT01110083 | First-in-Man, Dose-escalation Trial of c-Met Kinase Inhibitor EMD 1204831 in Subjects With Advanced Solid Tumors | terminated | Phase 1 | 38 | EMD SeronoINDUSTRY | 1 | Oct 22, 2013 | clinicaltrials |
| NCT00031681 | 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) | completed | Phase 1 | 41 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
| NCT00075634 | Decitabine, Doxorubicin, and Cyclophosphamide in Treating Children With Relapsed or Refractory Solid Tumors or Neuroblastoma | completed | Phase 1 | 21 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
| NCT00138177 | Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid Tumors | completed | Phase 1 | 54 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
| NCT00293345 | 3-AP and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
| NCT00929903 | Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment | completed | Phase 1 | 55 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
| NCT01951846 | To Determine the Maximum Tolerated Dose (MTD) of BIBF 1120 in Patients With Solid Tumours | completed | Phase 1 | 61 | Boehringer IngelheimINDUSTRY | 1 | Sep 27, 2013 | clinicaltrials |
| NCT01161836 | An Open-label Study Investigating the Disposition and QT/QTc Interval Effects of 400 mg [14C]-Iniparib(3.7 MBq, 100 µCi) | completed | Phase 1 | 7 | SanofiINDUSTRY | 1 | Sep 24, 2013 | clinicaltrials |
| NCT00006088 | Vinorelbine in Treating Patients With Metastatic or Advanced Solid Tumors | unknown | Phase 1 | — | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00023816 | Carbendazim in Treating Patients With Advanced Solid Tumors or Lymphoma | unknown | Phase 1 | — | Jonsson Comprehensive Cancer CenterOTHER | 0 | Sep 20, 2013 | clinicaltrials |
| NCT00060151 | GW786034 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Case Comprehensive Cancer CenterOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT01159301 | Entinostat and Sorafenib Tosylate in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory or Relapsed Acute Myeloid Leukemia | terminated | Phase 1 | 44 | National Cancer Institute (NCI)NIH | 1 | Sep 19, 2013 | clinicaltrials |
| NCT00024310 | Paclitaxel, Folic Acid, and Lometrexol in Treating Patients With Locally Advanced or Metastatic Solid Tumors | unknown | Phase 1 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | Sep 17, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Jan 7, 2014source: clinicaltrials